As the results above suggest that the effects of TNF-α on glioma cell proliferation are mediated by ANXA1, we explored expression of ANXA1 in 90 clinical specimens by IHC, the clinical features of which are shown in Table 1. Here, ANXA1 is linked to central nervous system cancer.